|
|
Article: Luteal-phase treatment may be best for PMDD.(Gynecology)
- Article from:
- OB GYN News
- Article date:
- October 15, 2004
- Author:
CopyrightCOPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PARIS -- Treatment of premenstrual dysphoric disorder may be more effective if a selective serotonin reuptake inhibitor is used throughout the luteal phase and not withheld until symptoms appear. Ellen W. Freeman, Ph.D., said in a poster presentation at the 24th Congress of the Collegium Internationale Neuro-Psychopharmacologicum.
In a preliminary study of 27 patients, treatment throughout the luteal phase led to a higher rate of patient improvement, compared with a symptom-onset approach, in patients who had more severe symptoms at baseline, she said.
The results also showed that escitalopram, the therapeutically active isomer of citalopram, was ...